Personal profile

Certifications and Licenses

1983Residency, Rhode Island Hospital
1985Fellowship, Boston University Medical Center
Rheumatology
Internal Medicine

Certifications and Licenses

1983Residency, Rhode Island Hospital
1985Fellowship, Boston University Medical Center
Internal Medicine
Rheumatology

Keywords

  • Interstitial Lung Disease
  • Stem Cells
  • Signal Transduction
  • Autoimmune Diseases
  • Fibrosis
  • Cutaneous Biology
  • Respiratory Diseases
  • Genetics
  • Inflammation
  • Pulmonary Hypertension
  • Scleroderma
  • Connective Tissue Associated Interstitial Lung Disease
  • Connective Tissue Biology
  • Big Data

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Systemic Scleroderma Medicine & Life Sciences
Skin Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Transforming Growth Factor beta Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Gene Expression Medicine & Life Sciences
Collagen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2017

1 Citations

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target

Marangoni, R. G., Masui, Y., Fang, F., Korman, B., Lord, G., Lee, J., Lakota, K., Wei, J., Scherer, P. E., Otvos, L., Yamauchi, T., Kubota, N., Kadowaki, T., Asano, Y., Sato, S., Tourtellotte, W. G. & Varga, J. Dec 1 2017 In : Scientific Reports. 7, 1, 4162

Research output: Research - peer-reviewArticle

Adiponectin
Skin
Therapeutics
Systemic Scleroderma
Fibrosis

Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis

Korman, B. D., Marangoni, R. G., Hinchcliff, M., Shah, S. J., Carns, M., Hoffmann, A., Ramsey-Goldman, R. & Varga, J. Oct 1 2017 In : Arthritis and Rheumatology. 69, 10, p. 2062-2068 7 p.

Research output: Research - peer-reviewArticle

Complement Factor D
Systemic Scleroderma
Pulmonary Hypertension
Adipokines
Adipose Tissue

Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)

Distler, O., Kevin, K. B., Distler, J. H. W., Assassi, S., Maher, T. M., Cottin, V., Varga, J., Coeck, C., Gahlemann, M., Sauter, W., Schmidt, H., Highland, K. B. & on behalf of the SENSCIS™ trial investigators Jan 1 2017 In : Clinical and Experimental Rheumatology. 35, p. S75-S81

Research output: Research - peer-reviewArticle

Systemic Scleroderma
Interstitial Lung Diseases
Randomized Controlled Trials
Placebos
nintedanib

Early-Life Gut Dysbiosis: A Driver of Later-Life Fibrosis?

Ho, K. J. & Varga, J. Nov 1 2017 In : Journal of Investigative Dermatology. 137, 11, p. 2253-2255 3 p.

Research output: Research - peer-reviewComment/debate

Dysbiosis
Fibrosis
Immunization
Type I DNA Topoisomerase
Skin
Systemic Scleroderma
Fibrosis
Ligands
Therapeutics
Fibroblasts